Organigram Global Inc. (OGI)
NASDAQ: OGI
· Real-Time Price · USD
1.39
-0.04 (-2.80%)
At close: Jun 17, 2025, 12:22 PM
Organigram Global Revenue Breakdown
| Period Ending | Sep 30, 2024 | Aug 31, 2022 | Aug 31, 2021 | Aug 31, 2020 |
|---|---|---|---|---|
| Direct To Patient Medical Revenue Revenue | 1.73M | 7.87M | 8.7M | 10.75M |
| Direct To Patient Medical Revenue Revenue Growth | -78.00% | -9.53% | -19.05% | n/a |
| International Business To Business Revenue | 9.65M | 15.14M | 386K | 3.27M |
| International Business To Business Revenue Growth | -36.25% | +3821.76% | -88.20% | n/a |
| Other Revenue Revenue | 97K | 115K | 202K | 245K |
| Other Revenue Revenue Growth | -15.65% | -43.07% | -17.55% | n/a |
| Wholesale To Licensed Producers Revenue Revenue | 5.31M | 1.3M | 2.06M | 15.18M |
| Wholesale To Licensed Producers Revenue Revenue Growth | +309.09% | -36.99% | -86.43% | n/a |
Operating Expense Breakdown
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | May 31, 2023 | Feb 28, 2023 | Nov 30, 2022 | Aug 31, 2022 | May 31, 2022 | Feb 28, 2022 | Nov 30, 2021 | Aug 31, 2021 | May 31, 2021 | Feb 28, 2021 | Nov 30, 2020 | Aug 31, 2020 | May 31, 2020 | Feb 29, 2020 | Nov 30, 2019 | Aug 31, 2019 | May 31, 2019 | Feb 28, 2019 | Nov 30, 2018 | Aug 31, 2018 | May 31, 2018 | Feb 28, 2018 | Nov 30, 2017 | Aug 31, 2017 | May 31, 2017 | Feb 28, 2017 | Nov 30, 2016 | Aug 31, 2016 | May 31, 2016 | Feb 29, 2016 | Nov 30, 2015 | Aug 31, 2015 | May 31, 2015 | Feb 28, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 23.34M | 17.19M | 14.3M | 15.63M | 22.14M | 17.34M | 22.61M | 20.23M | 15.85M | 16.05M | 18.15M | 18.21M | 13.4M | 12.5M | 13.29M | 13.44M | 11.28M | 10.89M | 11.54M | 11.35M | 14.45M | 10.55M | 16.03M | 10.71M | 9.59M | 5.5M | 4.86M | 3.94M | 3.82M | 2.59M | 2.71M | 1.7M | 1.91M | 1.43M | 1.3M | 1.09M | 887.91K | 765.19K | 612.08K | 493.97K | 731.47K |
| Selling, General, and Administrative Revenue Growth | +35.78% | +20.17% | -8.50% | -29.40% | +27.65% | -23.28% | +11.73% | +27.65% | -1.24% | -11.58% | -0.30% | +35.83% | +7.21% | -5.96% | -1.11% | +19.24% | +3.51% | -5.62% | +1.66% | -21.42% | +36.90% | -34.18% | +49.63% | +11.70% | +74.42% | +13.17% | +23.19% | +3.22% | +47.57% | -4.39% | +59.07% | -10.84% | +33.94% | +9.27% | +19.72% | +22.76% | +16.04% | +25.01% | +23.91% | -32.47% | n/a |
| Research and Development Revenue | 2.66M | 2.37M | 1.67M | 2.46M | 2.61M | 4.47M | 4.01M | 3.46M | 3.35M | 2.38M | 2.39M | 1.37M | 1.18M | 1.01M | 1.15M | 890K | 786K | 627K | 371K | 173K | 478K | 247K | 196K | 182K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Research and Development Revenue Growth | +12.37% | +42.11% | -32.24% | -5.60% | -41.66% | +11.48% | +15.71% | +3.43% | +40.50% | -0.29% | +74.07% | +15.96% | +16.65% | -11.51% | +28.88% | +13.23% | +25.36% | +69.00% | +114.45% | -63.81% | +93.52% | +26.02% | +7.69% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Sales and Marketing Revenue | 7.52M | 5.8M | 4.76M | 5.1M | 5.4M | 4.59M | n/a | 4.55M | 4.33M | 4.49M | 4.11M | 4.67M | 3.42M | 4.66M | 4.89M | 4.11M | 3.14M | 3.67M | 3.22M | 4.3M | 5.48M | 3.53M | 4.72M | 4.44M | 3.14M | 2.36M | 2.09M | 1.49M | 934K | 923K | 762K | 690.75K | 704.57K | 667.92K | 559.62K | 460.79K | 412.01K | 325.39K | 251.75K | 151.95K | 152.21K |
| Sales and Marketing Revenue Growth | +29.62% | +22.04% | -6.69% | -5.66% | +17.58% | n/a | -100.00% | +4.98% | -3.50% | +9.24% | -12.01% | +36.73% | -26.67% | -4.66% | +19.05% | +30.72% | -14.46% | +14.11% | -25.15% | -21.57% | +55.27% | -25.21% | +6.28% | +41.52% | +33.14% | +12.88% | +39.95% | +59.74% | +1.19% | +21.13% | +10.32% | -1.96% | +5.49% | +19.35% | +21.45% | +11.84% | +26.62% | +29.25% | +65.68% | -0.17% | n/a |